324 related articles for article (PubMed ID: 19398782)
1. Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2.
Scarpellini A; Germack R; Lortat-Jacob H; Muramatsu T; Billett E; Johnson T; Verderio EA
J Biol Chem; 2009 Jul; 284(27):18411-23. PubMed ID: 19398782
[TBL] [Abstract][Full Text] [Related]
2. Characterization of heparin-binding site of tissue transglutaminase: its importance in cell surface targeting, matrix deposition, and cell signaling.
Wang Z; Collighan RJ; Pytel K; Rathbone DL; Li X; Griffin M
J Biol Chem; 2012 Apr; 287(16):13063-83. PubMed ID: 22298777
[TBL] [Abstract][Full Text] [Related]
3. Interplay between transglutaminases and heparan sulphate in progressive renal scarring.
Burhan I; Furini G; Lortat-Jacob H; Atobatele AG; Scarpellini A; Schroeder N; Atkinson J; Maamra M; Nutter FH; Watson P; Vinciguerra M; Johnson TS; Verderio EA
Sci Rep; 2016 Oct; 6():31343. PubMed ID: 27694984
[TBL] [Abstract][Full Text] [Related]
4. RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling.
Wang Z; Collighan RJ; Gross SR; Danen EH; Orend G; Telci D; Griffin M
J Biol Chem; 2010 Dec; 285(51):40212-29. PubMed ID: 20929862
[TBL] [Abstract][Full Text] [Related]
5. Insights into the heparan sulphate-dependent externalisation of transglutaminase-2 (TG2) in glucose-stimulated proximal-like tubular epithelial cells.
Furini G; Burhan I; Huang L; Savoca MP; Atobatele A; Johnson T; Verderio EAM
Anal Biochem; 2020 Aug; 603():113628. PubMed ID: 32074489
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies from patients with celiac disease inhibit transglutaminase 2 binding to heparin/heparan sulfate and interfere with intestinal epithelial cell adhesion.
Teesalu K; Panarina M; Uibo O; Uibo R; Utt M
Amino Acids; 2012 Feb; 42(2-3):1055-64. PubMed ID: 21847613
[TBL] [Abstract][Full Text] [Related]
7. Transglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrix.
Lortat-Jacob H; Burhan I; Scarpellini A; Thomas A; Imberty A; Vivès RR; Johnson T; Gutierrez A; Verderio EA
J Biol Chem; 2012 May; 287(22):18005-17. PubMed ID: 22442151
[TBL] [Abstract][Full Text] [Related]
8. Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis.
Scarpellini A; Huang L; Burhan I; Schroeder N; Funck M; Johnson TS; Verderio EA
J Am Soc Nephrol; 2014 May; 25(5):1013-27. PubMed ID: 24357671
[TBL] [Abstract][Full Text] [Related]
9. Spotlight on the Transglutaminase 2-Heparan Sulfate Interaction.
Furini G; Verderio EAM
Med Sci (Basel); 2019 Jan; 7(1):. PubMed ID: 30621228
[TBL] [Abstract][Full Text] [Related]
10. The interaction of heparan sulfate proteoglycans with endothelial transglutaminase-2 limits VEGF165-induced angiogenesis.
Beckouche N; Bignon M; Lelarge V; Mathivet T; Pichol-Thievend C; Berndt S; Hardouin J; Garand M; Ardidie-Robouant C; Barret A; Melino G; Lortat-Jacob H; Muller L; Monnot C; Germain S
Sci Signal; 2015 Jul; 8(385):ra70. PubMed ID: 26175493
[TBL] [Abstract][Full Text] [Related]
11. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
[TBL] [Abstract][Full Text] [Related]
12. Novel interactions of TG2 with heparan sulfate proteoglycans: reflection on physiological implications.
Verderio EA; Scarpellini A; Johnson TS
Amino Acids; 2009 Apr; 36(4):671-7. PubMed ID: 18607676
[TBL] [Abstract][Full Text] [Related]
13. Cellular adhesion responses to the heparin-binding (HepII) domain of fibronectin require heparan sulfate with specific properties.
Mahalingam Y; Gallagher JT; Couchman JR
J Biol Chem; 2007 Feb; 282(5):3221-30. PubMed ID: 17130131
[TBL] [Abstract][Full Text] [Related]
14. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
[TBL] [Abstract][Full Text] [Related]
15. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation.
Fisher MC; Li Y; Seghatoleslami MR; Dealy CN; Kosher RA
Matrix Biol; 2006 Jan; 25(1):27-39. PubMed ID: 16226436
[TBL] [Abstract][Full Text] [Related]
16. Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2.
Clayton A; Thomas J; Thomas GJ; Davies M; Steadman R
Kidney Int; 2001 Jun; 59(6):2084-94. PubMed ID: 11380810
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2 interacts with syndecan-4 and CD44 at the surface of human macrophages to promote removal of apoptotic cells.
Nadella V; Wang Z; Johnson TS; Griffin M; Devitt A
Biochim Biophys Acta; 2015 Jan; 1853(1):201-12. PubMed ID: 25449226
[TBL] [Abstract][Full Text] [Related]
18. Cell surface phosphatidylinositol-anchored heparan sulfate proteoglycan initiates mouse melanoma cell adhesion to a fibronectin-derived, heparin-binding synthetic peptide.
Drake SL; Klein DJ; Mickelson DJ; Oegema TR; Furcht LT; McCarthy JB
J Cell Biol; 1992 Jun; 117(6):1331-41. PubMed ID: 1607392
[TBL] [Abstract][Full Text] [Related]
19. Expression of heparan sulfate proteoglycans in murine models of experimental colitis.
Patterson AM; Delday MI; van Kuppevelt TH; Loh G; Blaut M; Haller D; Grant G; Kelly D
Inflamm Bowel Dis; 2012 Jun; 18(6):1112-26. PubMed ID: 21987406
[TBL] [Abstract][Full Text] [Related]
20. Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells.
Lim HC; Multhaupt HA; Couchman JR
Mol Cancer; 2015 Jan; 14(1):15. PubMed ID: 25623282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
